Atb Cap Markets Estimates Organigram Q1 Earnings

Organigram Holdings Inc. (TSE:OGIFree Report) – Equities researchers at Atb Cap Markets issued their Q1 2025 earnings estimates for shares of Organigram in a research note issued to investors on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes anticipates that the company will post earnings of ($0.03) per share for the quarter. The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.10) EPS.

A number of other research firms also recently issued reports on OGI. Canaccord Genuity Group reduced their price target on shares of Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating for the company in a research report on Monday, December 9th. ATB Capital dropped their price objective on Organigram from C$5.25 to C$3.50 in a research note on Tuesday, December 17th.

Check Out Our Latest Stock Analysis on Organigram

Organigram Stock Up 6.2 %

OGI stock opened at C$2.22 on Monday. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13. The company’s 50-day moving average price is C$2.26 and its 200 day moving average price is C$2.30. Organigram has a 52 week low of C$1.61 and a 52 week high of C$3.95. The company has a market cap of C$241.03 million, a P/E ratio of -0.88, a P/E/G ratio of 0.42 and a beta of 1.13.

Insider Buying and Selling at Organigram

In other news, Senior Officer Paolo De Luca sold 12,014 shares of the business’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total value of C$30,275.28. 31.32% of the stock is currently owned by insiders.

Organigram Company Profile

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Further Reading

Earnings History and Estimates for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.